World Osteoporosis Day, MHRA Antidepressant Review, and Sheffield Spotlight

The Medicines and Healthcare products Regulatory Agency (MHRA) announced on 14 October 2026 the introduction of new and updated patient information for antidepressant medicines following an extensive review involving patients, families, and independent experts.

The review sought to strengthen safety information and improve patient understanding of both the benefits and potential risks associated with antidepressant therapy. The updated guidance will appear in patient information leaflets and support materials for commonly prescribed antidepressants across the UK.

This regulatory update reflects a growing emphasis on transparent, patient-centred communication in mental health prescribing—a topic that frequently arises in medical school interviews. Candidates should be prepared to discuss how accessible, balanced information supports informed consent and shared decision-making, particularly in psychiatric care where treatment adherence and patient autonomy are critical.

Why this matters for interviews: Expect questions on how regulatory bodies balance public protection with access to effective treatments, or how you would support a patient who is hesitant about starting medication after reading safety warnings. Consider the interplay between beneficence (providing effective treatment), non-maleficence (minimising harm), and autonomy (respecting patient choice)—the reasoning framework explored in The Four Pillars of Medical Ethics.

The MHRA review underscores the importance of evolving safety standards in response to real-world evidence and patient feedback—an example of regulatory responsiveness that applicants can reference when discussing NHS innovation, pharmacovigilance, or mental health policy.

World Osteoporosis Day falls this Sunday, 20 October—just two days from now—offering a timely lens through which to examine bone health, fracture prevention, and health inequalities in the UK.

The scale of the problem

Over 3.5 million people in the UK live with osteoporosis, a condition that weakens bones and dramatically increases fracture risk. One in two women and one in five men over 50 will experience an osteoporotic fracture in their lifetime. Hip fractures—one of the most serious consequences—carry profound personal and system-level costs: around 25% of patients die within one year of a hip fracture, and 80% are unable to return to their pre-fracture level of independence.

In England, osteoporosis causes around 500,000 fractures annually. Yet despite this burden, the condition remains underdiagnosed and undertreated. A recent study found that only 12% of people awaiting joint surgery had undergone bone density (DXA) testing within the previous year, and fewer than 21% of those with diagnosed osteoporosis were receiving appropriate treatment.

A silent crisis

Osteoporosis is often called a 'silent disease' because bone loss progresses without symptoms until a fracture occurs. This presents a significant challenge: by the time the condition is diagnosed, considerable damage has already been done. Awareness days like World Osteoporosis Day aim to shift the focus upstream—encouraging risk assessment, lifestyle modification, and early intervention before the first fracture.

NICE published updated guidance in July 2026 (NG259) on osteoporosis risk assessment, aiming to improve identification of at-risk adults and standardise fracture risk tools across the NHS. Yet implementation remains patchy, particularly in deprived communities where access to screening and treatment is lower.

The equity question

Research from UK primary care data shows that men in the most deprived areas have a 45% higher risk of being diagnosed with osteoporosis compared to those in the least deprived areas—but paradoxically, they are also less likely to receive timely treatment. Women show smaller but still significant deprivation-related gaps. This raises uncomfortable questions: is osteoporosis screening reaching the people who need it most? Are we systematically failing certain groups?

What makes a good awareness day?

World Osteoporosis Day prompts us to ask: what does effective health promotion look like? Is a single day of social media posts enough to shift the dial on a condition affecting millions? Or does meaningful change require sustained investment in Fracture Liaison Services, primary care risk-assessment tools, and public education campaigns that reach beyond the 'worried well'?

As future doctors, you'll encounter osteoporosis not as a standalone diagnosis but as part of the complex, multimorbid reality of caring for older patients. Understanding the condition means understanding falls prevention, polypharmacy, frailty, and the social determinants that make some people more vulnerable than others.

World Osteoporosis Day is a reminder that behind every awareness campaign lies a public health challenge—and an opportunity to do better.

Osteoporosis is common, serious, and largely preventable—yet most people with the condition remain undiagnosed until they suffer a fracture. With World Osteoporosis Day approaching on 20 October, the question arises: should the NHS introduce universal bone density screening for everyone over 50?

The case for universal screening

Beneficence: Early detection allows timely intervention with lifestyle advice, calcium and vitamin D supplementation, or pharmacological treatment (bisphosphonates, for example). Evidence suggests that up to 25% of hip fractures and 40% of all fragility fractures in older adults could be prevented with appropriate treatment. Screening could save lives, preserve independence, and reduce the enormous personal and economic costs of fractures.

Justice: Currently, access to DXA scanning (the gold-standard test for bone density) is inconsistent. Wealthier, more health-literate patients are more likely to request assessment; those in deprived areas—who often have higher fracture risk—are less likely to be tested or treated. Universal screening would level the playing field and reduce health inequalities.

The case against

Non-maleficence: Screening healthy people risks overdiagnosis and overtreatment. Not everyone with low bone density will fracture, and bisphosphonates carry rare but serious side effects (osteonecrosis of the jaw, atypical femoral fractures). Labelling millions of asymptomatic people as 'at risk' may cause anxiety and medicalise normal ageing.

Resource allocation (justice): DXA scanners are expensive and not universally available. A national screening programme would require significant investment in equipment, radiographers, and follow-up pathways—resources that might deliver greater health gains if spent on, for example, falls prevention, smoking cessation, or management of multimorbidity in frail older adults.

Current NICE guidance (NG259, published July 2026) recommends targeted risk assessment using tools like FRAX or QFracture, rather than blanket screening. The approach prioritises those with known risk factors (previous fracture, steroid use, family history, low BMI) and aims to balance early detection with stewardship of finite NHS resources.

Discussion points for interviews

• How do you weigh population-level benefit against individual risk of harm in screening programmes?
• Should access to preventive care depend on ability to self-advocate, or is there an ethical imperative to offer proactive screening to all?
• When resources are limited, how do you decide between competing health priorities?
• What role should patient autonomy play—should people be able to opt in to screening even if not deemed 'high risk'?

This dilemma sits at the intersection of clinical evidence, health economics, and equity. There is no single 'right' answer—but your ability to reason through the trade-offs, acknowledge uncertainty, and apply ethical principles will demonstrate the kind of thinking medicine demands.

For a deeper dive into the frameworks that underpin questions like this, see The Four Pillars of Medical Ethics.

Multiple Mini Interviews (MMIs) are the dominant format across UK medical schools, and one of the most challenging station types is the role-play scenario. Unlike traditional discussion stations, role-plays require you to interact with an actor in real time—testing communication, empathy, and professionalism under pressure.

What are role-play stations?

You'll be given a brief scenario outside the station (usually 1–2 minutes to read), then enter and engage with an actor playing a patient, relative, colleague, or friend. Common scenarios include:

• Breaking difficult news to a friend (e.g., they didn't get into medical school)
• Persuading a peer to seek help for stress or substance use
• Explaining a medical concept to a 'patient' who is anxious or misinformed
• Responding to a complaint or angry relative

You won't be expected to have clinical knowledge, but you will be assessed on communication skills, rapport-building, empathy, listening, and professionalism.

Five strategies for success

1. Read the brief carefully—and stick to your role

The scenario will specify who you are (yourself, a fellow student, a healthcare assistant) and what you're being asked to do (e.g., 'express your concerns to your friend' or 'explain why attending all placements is important'). Don't invent extra information or overstep your role. If you're a student, don't give medical advice; if you're asked to listen, don't dominate the conversation.

2. Start with rapport, not your agenda

Many candidates jump straight into 'fixing' the problem. Resist this. Open with warmth, empathy, and an open question:

• 'Thanks for meeting me—how have you been feeling recently?'
• 'I wanted to talk because I've noticed you seem a bit down. Is now an okay time?'

This mirrors real clinical communication: you earn the right to be heard by first demonstrating that you're listening.

3. Use reflective listening and signposting

Show you're processing what the actor says by reflecting back:

• 'It sounds like you're feeling really overwhelmed.'
• 'I can see this has been really tough for you.'

If you need to shift topic or deliver difficult information, signpost clearly:

• 'I want to talk about something that might be hard to hear—is that okay?'
• 'Can I share what I've been noticing?'

This prevents the conversation feeling abrupt or dismissive.

4. Don't panic if the actor is difficult

Some actors will be defensive, tearful, or angry—this is deliberate. You're being assessed on how you respond under pressure. Stay calm, validate their feelings, and avoid being defensive:

• 'I can see you're upset, and that's completely understandable.'
• 'I'm not here to judge—I just want to make sure you're okay.'

If they refuse help, acknowledge their autonomy but gently encourage them to reconsider or suggest small next steps (e.g., 'Would you be open to just talking to someone once?').

5. End with a clear next step

Don't let the station fizzle out. Even if the conversation has been difficult, offer a concrete next action:

• 'Why don't we go and speak to the student support team together?'
• 'Can I check in with you again tomorrow?'
• 'I think it would really help to talk to your GP—would you like me to come with you?'

This demonstrates professionalism, follow-through, and care.

Common mistakes to avoid

• Lecturing: Role-plays are dialogues, not monologues. If you're doing all the talking, you're not listening.
• Ignoring emotional cues: If the actor looks upset, acknowledge it. Don't plough on with your script.
• Overcomplicating: You don't need to solve everything in 7 minutes. Showing empathy, active listening, and a sensible next step is enough.
• Breaking character: Stay in role, even if the scenario feels artificial. Examiners are assessing your ability to engage authentically.

Practice makes natural

Role-plays feel awkward at first, but they become far more natural with practice. Run mock stations with friends, teachers, or mentors—ideally using the kind of scenarios listed in our Interview Preparation resources. Record yourself and watch back: are you making eye contact? Using open body language? Listening, or just waiting to speak?

Role-play stations are designed to test the interpersonal skills that underpin good doctoring. Master them, and you'll stand out.

Interview season is well underway, and the margin between offers and rejections is often finer than you think. Here are three small, high-impact actions you can take this week to stay sharp.

1. Update your 'current affairs' mental file with one NHS story per week

Interviewers love asking 'What recent development in medicine or healthcare has interested you?' Don't get caught out. This week, set aside 10 minutes to read one credible story—from the NHS England website, a gov.uk press release, or a BMJ news article—and prepare a 60-second summary covering:

• What happened
• Why it matters to patients or the NHS
• One question or challenge it raises

Example from this week: the MHRA's updated antidepressant safety guidance (covered in our Medical News section above). You could discuss how regulatory transparency supports informed consent, or the tension between public reassurance and honest communication about medication risks.

Why it works: You demonstrate intellectual curiosity, engagement with the real world of healthcare, and an ability to think beyond textbooks. For curated NHS and policy updates, explore NHS Pressures and the Workforce.

2. Rehearse one 'Tell me about a time…' answer out loud every day

MMI and panel interviews frequently include competency-based questions:

• 'Tell me about a time you worked in a team.'
• 'Describe a situation where you faced a difficult ethical choice.'
• 'Give an example of when you showed leadership.'

Most candidates have answers prepared in their heads—but speaking them aloud under time pressure is a different skill. This week, pick one example each day, set a timer for 90 seconds, and deliver your answer as if you're in the interview room.

Use a clear structure (situation, task, action, result), speak at a natural pace, and avoid filler words ('um', 'like', 'basically'). Recording yourself on your phone is uncomfortable but transformative—you'll quickly notice verbal tics, lack of eye contact, or rambling.

Why it works: Fluency comes from repetition. By the time you sit down in front of an interviewer, your answers will feel natural rather than rehearsed. For more on structuring responses under pressure, see Structuring Answers Under Pressure.

3. Refresh one ethical framework—and apply it to a real case

Ethics questions can feel abstract until you ground them in real scenarios. This week, choose one principle from the four pillars—autonomy, beneficence, non-maleficence, or justice—and apply it to a case you've read about or experienced.

Example: Re-read the osteoporosis screening dilemma in our Medical Ethics Corner (above). Which principle would you prioritise if you were designing NHS policy? What about if you were the GP advising an individual patient? Notice how context shifts the balance.

Why it works: Interviewers aren't looking for a 'right' answer—they want to see structured ethical reasoning. Practising real applications helps you move beyond rote definitions to nuanced, thoughtful discussion. Dive deeper with The Four Pillars of Medical Ethics.

---

This week's mantra: Small, consistent actions compound. Ten minutes a day on current affairs, 90 seconds rehearsing an answer, and one ethical case study will leave you sharper, calmer, and more prepared than 90% of candidates.

The University of Sheffield offers two routes into its MBChB Medicine programme: a five-year standard-entry course (A100) and a four-year graduate-entry pathway (A101) designed specifically for life science graduates from widening-participation backgrounds.

Course structure

Standard Entry (A100): A traditional five-year MBChB with patient-centred, research-led teaching. From day one, you'll learn in real clinical environments—meeting patients, shadowing doctors, and developing practical skills in hospitals and GP surgeries across South Yorkshire. The curriculum integrates basic sciences with clinical application, ensuring you understand not just what happens in disease, but why it matters to the patient in front of you.

Graduate Entry (A101): If you hold a 2:1 or higher in a life sciences degree, meet widening-participation criteria, and achieved at least BBB at A-level (including Chemistry or Biology), you may be eligible for the accelerated four-year programme. After a six-week induction, you jump straight into Phase 2 of the standard MBChB, completing the course in four years rather than five. Note: this route is only open to UK applicants from under-represented backgrounds and has just 15 places annually.

Entry requirements (A100 – Standard Entry, 2027 entry)

• A-levels: AAA, including Chemistry or Biology and a second science subject (Biology, Chemistry, Maths, Physics, or Psychology). You must also pass the practical element of any science A-levels taken.
• GCSEs: Five at grade 7/A, with at least grade 6/B in Maths, English Language, and the sciences (Dual Award Science acceptable).
• International Baccalaureate: 36 points overall, with 6 in three Higher Level subjects including Chemistry or Biology and a second science; minimum 4 in all Standard Level subjects.
• Access to HE Diploma: 45 Distinctions at Level 3 in Medicine (only if you haven't studied science A-levels or have been out of full-time education for three years). Distance learning is not accepted.
• English language: GCSE English Language grade 6/B, or IELTS 7.5 with minimum 7.0 in each component.

Admissions process

UCAT: All applicants must sit the UCAT in the year of application. For 2027 entry, Sheffield has set a minimum threshold of 1800/2700. Applications are ranked by UCAT score, and only those with the highest scores are invited to interview. UCAT results are valid for one cycle only—reapplicants must resit.

Interview: Sheffield uses a Multiple Mini Interview (MMI) format for home applicants, conducted in person. International applicants are invited to an online panel interview. The MMI typically consists of several timed stations assessing communication, ethical reasoning, empathy, teamwork, and motivation for medicine. Work experience is discussed at interview but is not scored separately in the application.

Competition ratios (2027 entry):
- Home applicants per place: 7
- Home applicants per interview: 2
- International applicants per place: 16

Sheffield does not score personal statements separately, but clinical and non-clinical experience will be explored during the MMI.

Widening participation: Access to Sheffield (Medicine)

Sheffield is strongly committed to widening access. The Access to Sheffield (Medicine) programme offers targeted support, mentoring, and enrichment activities for students from under-represented backgrounds, including those eligible for Pupil Premium, care-leavers, and students attending schools with low progression to higher education. Participation in the programme is noted positively during application review.

What makes Sheffield distinctive?

• Early clinical exposure: You're in hospitals and GP practices from week one, not year three.
• Social accountability placements: All students work with over 130 charities and community organisations, developing insight into the social determinants of health and the role of the doctor beyond the clinic.
• Research-led teaching: Sheffield is a Russell Group university with a global research reputation, and that ethos permeates the MBChB—expect teaching informed by the latest evidence and opportunities to engage in student-selected components and research projects.
• Integrated curriculum: The course is designed around clinical cases and patient stories, not isolated disciplines. Anatomy, physiology, pharmacology, and ethics are taught in context, helping you see the bigger picture from day one.

Key links and further reading

• UCAS Course Page (A100): Standard Entry Medicine
• Medical Schools Council Profile: MBChB Medicine (A100)
• Interview format guidance: Multiple Mini Interviews explained

For strategic advice on selecting medical schools based on UCAT score, entry requirements, and interview format, explore Application Strategy and TrueScore UCAT Predictions.

Final thoughts

Sheffield is an excellent choice if you value early clinical contact, a socially engaged curriculum, and a supportive widening-participation ethos. The UCAT threshold (1800 for 2027) is competitive but accessible, and the MMI format rewards candidates who can think on their feet, communicate clearly, and demonstrate genuine insight into what it means to be a doctor. If you're a graduate from an under-represented background, the A101 route offers a rare and valuable accelerated pathway into medicine.

NextGenMedPrep TrueScore for University of Sheffield: ~2150/2700 — the UCAT score we predict you'll need to reach interview (2027 entry). See all predictions and check our Medical School Rankings.